Fibroblast growth factor receptor 4 (FGFR4): a targetable regulator of drug resistance in colorectal cancer.
about
Genomic diversity of colorectal cancer: Changing landscape and emerging targetsCancer drug resistance: redox resetting renders a wayFibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implicationsFibroblast Growth Factor Receptor Family Members as Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review.Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical applicationDevelopment of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors.Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.Electrochemical sensor for rapid determination of fibroblast growth factor receptor 4 in raw cancer cell lysates.Multiple faces of fibroblast growth factor-23Dragon (RGMb) induces oxaliplatin resistance in colon cancer cells.Fibroblast growth factor receptor 4 (FGFR4) and fibroblast growth factor 19 (FGF19) autocrine enhance breast cancer cells survival.Fibroblast growth factor receptor 4 induced resistance to radiation therapy in colorectal cancer.Targeting FGF receptors in colorectal cancer: from bench side to bed side.Silencing of FGFR4 could influence the biological features of gastric cancer cells and its therapeutic value in gastric cancer.Predictors of chemotherapy efficacy in non-small-cell lung cancer: a challenging landscape.Regulation of metastasis of pediatric multiple myeloma by MMP13.Deguelin-induced blockade of PI3K/protein kinase B/MAP kinase signaling in zebrafish and breast cancer cell lines is mediated by down-regulation of fibroblast growth factor receptor 4 activity.Genomics alterations of metastatic and primary tissues across 15 cancer types.FGFR2 amplification is predictive of sensitivity to regorafenib in gastric and colorectal cancers in vitro.Cytotoxic Conjugates of Fibroblast Growth Factor 2 (FGF2) with Monomethyl Auristatin E for Effective Killing of Cells Expressing FGF Receptors.
P2860
Q26739052-923F3532-0B5B-4338-870C-8B6E59936EB7Q26750753-54F2E82E-8CB8-4C4F-8483-C3EE83749E97Q26801718-68BE3FEA-0904-4496-A534-4034CDDCD547Q27853178-17C9B59E-02A3-4299-A259-EE8913815451Q28079309-B58B6620-3A35-461F-8628-E96F93DD53CDQ34525925-F2405630-E0CB-43F9-BBBD-47630E1A46B4Q35069479-4EFB0167-4BC6-4814-9D87-9D68C6250D0FQ36334104-99DE8AE1-A24D-448F-8D74-919C8C338108Q37312020-CB504387-98E2-46C0-A731-2F06888DE0FCQ37565369-FA2ABA1A-6CF3-484B-B1E7-3C435C251BE5Q37628912-E353F3E1-99B2-44E4-9F9E-3C3F6195671DQ37688471-202261D1-021F-46D2-9875-1FC3BB7CB8D0Q38465837-E08440C5-ACB0-4264-96FF-E4EE338BCE44Q38830668-AD19D534-8490-4F17-B24E-9E6AD47C81A6Q38922208-F8B40C89-CF26-46E8-96A3-7981FAD893DBQ38990794-88623942-4F70-481D-A125-1D336C2EF5E1Q39382063-986DEBDB-AF1E-4384-AFD6-266934809C48Q42378874-8FC1A0B4-5438-40AD-B2B6-15B519FA947CQ55478389-5C3CCBD7-EF97-45F1-AD11-695A59CFFDA5Q55669491-8BF3B369-52DF-440E-AFAE-34EF68EA28A4
P2860
Fibroblast growth factor receptor 4 (FGFR4): a targetable regulator of drug resistance in colorectal cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Fibroblast growth factor recep ...... sistance in colorectal cancer.
@en
type
label
Fibroblast growth factor recep ...... sistance in colorectal cancer.
@en
prefLabel
Fibroblast growth factor recep ...... sistance in colorectal cancer.
@en
P2093
P2860
P50
P356
P1476
Fibroblast growth factor recep ...... sistance in colorectal cancer.
@en
P2093
D B Longley
J K Blayney
L Stevenson
M Salto-Tellez
P G Johnston
S Van Schaeybroeck
P2860
P2888
P356
10.1038/CDDIS.2014.10
P577
2014-02-06T00:00:00Z
P5875
P6179
1045915916